Synthetic biology using febit’s Geniom technology platform
From biochips to biobricks
Synthetic biology using febit’s Geniom technology platform
De novo dsDNA-synthesis up offers enormous potential and new possibilities with regard to the production of new genes, gene clusters or even whole genomes. Customized production of synthetic DNA provides immediate access to any sequence needed and supports a wide range of possible applications, including engineered molecular biology products, synthetic genes, novel pharmacons and bio-engineered therapeutics.
The unique Geniom technology platform offers an unprecedented and revolutionary approach to modern research in the life sciences. The state of the art device Geniom provides the research community with an excellent toolset for discovery: biochips and biobricks, offering the user a broad range of experimental opportunities:
Biochips: The Geniom device enables the on demand design, synthesis, application and analysis of user-specified biochips in the own laboratory.
The digital-to-DNA workflow allows the swift processing of the most recent sequence data from internet databases into workable biochip experiments and the fine-tuning of such experimental approaches within a short time frame.
In a fully integrated benchtop device Geniom offers not only unparalleled speed and flexibility but also the complete privacy of sensitive research data.
Biobricks: The proprietary Geniom DNA synthesis technology is applied in the biochip based production of any desired DNA sequence. Biochip derived oligonucleotides can then be used to produce synthetic genes, gene clusters or even artificial chromosomes or to prepare pools of individual biobricks thus offering a wide range of applications in synthetic and constructive biology.